Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kristine M. Zanotti, MD
MacDonald Physicians, Incorporated at University MacDonald Womens Hospital
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Union Hospital Cancer Program at Union Hospital
Elkton, Maryland, United States
- Umass Memorial Cancer Center - University Campus
Worcester, Massachusetts, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Alamance Cancer Center at Alamance Regional Medical Center
Burlington, North Carolina, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center at Fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Metrohealth Cancer Care Center at Metrohealth Medical Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Mount Carmel Health - West Hospital
Columbus, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
- Hillcrest Cancer Center at Hillcrest Hospital
Mayfield Heights, Ohio, United States
- Lake/university Ireland Cancer Center
Mentor, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital
Abington, Pennsylvania, United States
- Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Upmc Cancer Center at Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
- Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States
- Carilion Gynecologic Oncology Associates
Roanoke, Virginia, United States
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 31 Jan 2012
- Completion
- —
- Last update posted
- 18 Jul 2018
- Registered enrollment
- 71
- Registry id
- NCT00569673
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.